RECRUITING

Accelerated Resolution Therapy for Early Maladaptive Grief

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.

Official Title

Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical Trial

Quick Facts

Study Start:2023-11-17

Study Completion:2028-03-14

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05624879

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Primary caregiver of immediate family member who has a life expectancy of less than 12 months * Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief * Denial of suicidal ideation or intent, with no evidence of psychotic behavior.	* Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART). * Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia). * Score of \> 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence. * Cognitive impairment (SPMSQ \> 4 errors).

Inclusion Criteria

Exclusion Criteria

* Primary caregiver of immediate family member who has a life expectancy of less than 12 months
* Score of 30 or higher on the PG-12-R, indicating clinically significant pre-loss grief
* Denial of suicidal ideation or intent, with no evidence of psychotic behavior.

* Since becoming a family caregiver (FCG), they have engaged in another trauma based psychotherapeutic regimen (EMDR, prolonged exposure therapy, trauma focused cognitive behavioral therapy) that could influence response to accelerated resolution therapy (ART).
* Self-reported or clinically assessed major psychiatric disorder (e.g., bipolar disorder, schizophrenia).
* Score of \> 2 on the adapted CAGE questionnaire indicating alcohol /drug dependence.
* Cognitive impairment (SPMSQ \> 4 errors).

Contacts and Locations

Study Contact

Katharine E Sheffield, MA, CCRP

CONTACT

904-953-3972

Sheffield.Katharine@mayo.edu

Principal Investigator

Cindy Tofthagen, PhD

PRINCIPAL_INVESTIGATOR

Mayo Clinic

Study Locations (Sites)

Mayo Clinic Florida

Jacksonville, Florida, 32224

United States

Mayo Clinic

Rochester, Minnesota, 55905

United States

Collaborators and Investigators

Sponsor: Mayo Clinic

Cindy Tofthagen, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-17

Study Completion Date2028-03-14

Study Record Updates

Study Start Date2023-11-17

Study Completion Date2028-03-14

Terms related to this study

Keywords Provided by Researchers

Family Caregiver

Additional Relevant MeSH Terms

Grief